GondolaBio
Develops clinical-stage therapeutics for rare genetic diseases.
biotechpharmaceuticals
Company facts
- Founded
- 2024
- Employees
- 45
- Headquarters
- United States
- Type
- Private
- Funding
- Corporate Round · $300M · 2024
- Subsidiaries
- Portal Therapeutics
Open positions
1 job
3 views 3 months ago
Associate/ Director, Regulatory Affairs
Open 69d RemoteNorth America
United States
Palo Alto, CA- HybridCompany Background GondolaBio is a collection of biopharmaceutical companies focused on developing next-generation therapeutics for genetic diseases. Originally carved out of BridgeBio, GondolaBio secured $300M in…